Barclays’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95M | Buy |
143,884
+110,984
| +337% | +$1.5M | ﹤0.01% | 2251 |
|
|
2025
Q1 | $522K | Sell |
32,900
-13,496
| -29% | -$214K | ﹤0.01% | 2826 |
|
|
2024
Q4 | $571K | Buy |
46,396
+8,178
| +21% | +$101K | ﹤0.01% | 2978 |
|
|
2024
Q3 | $463K | Buy |
38,218
+28,208
| +282% | +$342K | ﹤0.01% | 3038 |
|
|
2024
Q2 | $118K | Sell |
10,010
-3,651
| -27% | -$43K | ﹤0.01% | 3298 |
|
|
2024
Q1 | $176K | Sell |
13,661
-13,113
| -49% | -$169K | ﹤0.01% | 3406 |
|
|
2023
Q4 | $230K | Buy |
26,774
+24,320
| +991% | +$209K | ﹤0.01% | 3447 |
|
|
2023
Q3 | $23K | Sell |
2,454
-324
| -12% | -$3.04K | ﹤0.01% | 3874 |
|
|
2023
Q2 | $47K | Sell |
2,778
-9,758
| -78% | -$165K | ﹤0.01% | 3703 |
|
|
2023
Q1 | $196K | Buy |
+12,536
| New | +$196K | ﹤0.01% | 3158 |
|